Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2009

01-06-2009 | Original Article

Influence of Previously Ingested Wheat on Fasting Breath Hydrogen in Celiac Patients

Authors: S. V. Rana, S. Sharma, S. K. Sinha, J. Kaur, K. K. Prasad, K. Singh

Published in: Digestive Diseases and Sciences | Issue 6/2009

Login to get access

Abstract

The excretion of hydrogen in breath commonly persists, despite an overnight fast. Although the elevation of hydrogen concentration above the fasting value after the administration of a test sugar is evidence of malabsorption, the level of the fasting value itself in untreated celiac patients is unknown. Therefore, we studied the fasting breath hydrogen (FBH2) concentration in 40 healthy controls, 35 subjects with functional bowel disorders, and 30 patients of untreated celiac disease with and without bread or wheat diet one day before the test. The fasting level of hydrogen concentration in untreated celiac patients (28.7 ± 19.5 ppm) was significantly higher than those in healthy volunteers (9.5 ± 3.4 ppm) and subjects with functional bowel disorders (10.6 ± 4.5 ppm). The percentage of patients with elevated H2 fasting levels in untreated celiac disease (82.5%) was significantly higher than that in healthy controls (10%) and subjects with functional bowel disorders (17.1%). In 30 celiac patients, studied with and without wheat-free diet one day before the test, the fasting hydrogen levels decreased from 28.7 ± 19.5 ppm to 10.6 ± 3.5 ppm, and becoming normal in all patients of celiac disease. Our results show that the patients of untreated celiac disease should be instructed not to eat things made up of wheat one day before hydrogen breath testing so that the normal fasting hydrogen concentration can be obtained and false-negative hydrogen breath test results can be avoided.
Literature
4.
go back to reference West J, Lloyd CA, Hill PG, et al. IgA-antitissue-transglutaminase: validation of a commercial assay for diagnosing celiac disease. Clin Lab (Zaragoza). 2002;48:241–246. West J, Lloyd CA, Hill PG, et al. IgA-antitissue-transglutaminase: validation of a commercial assay for diagnosing celiac disease. Clin Lab (Zaragoza). 2002;48:241–246.
5.
go back to reference Di Stefano M, Miceli E, Missanelli A, Malservisi S, Strocchi A, Corazza GR. Fermentation of endogenous substrates is responsible for increased fasting breath hydrogen levels in celiac disease. J Lab Clin Med. 2004;143(3):163–168. doi:10.1016/j.lab.2003.11.006.PubMedCrossRef Di Stefano M, Miceli E, Missanelli A, Malservisi S, Strocchi A, Corazza GR. Fermentation of endogenous substrates is responsible for increased fasting breath hydrogen levels in celiac disease. J Lab Clin Med. 2004;143(3):163–168. doi:10.​1016/​j.​lab.​2003.​11.​006.PubMedCrossRef
7.
go back to reference Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988;95(4):982–988.PubMed Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988;95(4):982–988.PubMed
10.
go back to reference Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med. 1969;17; 281(3):122–127. Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med. 1969;17; 281(3):122–127.
11.
go back to reference Levitt MD, Donaldson RM. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J Lab Clin Med. 1970;75(6):937–945.PubMed Levitt MD, Donaldson RM. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J Lab Clin Med. 1970;75(6):937–945.PubMed
12.
go back to reference Bond JH, Levitt MD. Use of pulmonary hydrogen (H2) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients. J Clin Invest. 1972;51(5):1219–1225. doi:10.1172/JCI106916.PubMedCrossRef Bond JH, Levitt MD. Use of pulmonary hydrogen (H2) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients. J Clin Invest. 1972;51(5):1219–1225. doi:10.​1172/​JCI106916.PubMedCrossRef
13.
go back to reference Kotler DP, Holt PR, Rosensweig NS. Modification of the breath hydrogen test: increased sensitivity for the detection of carbohydrate malabsorption. J Lab Clin Med. 1982;100(5):798–805.PubMed Kotler DP, Holt PR, Rosensweig NS. Modification of the breath hydrogen test: increased sensitivity for the detection of carbohydrate malabsorption. J Lab Clin Med. 1982;100(5):798–805.PubMed
14.
go back to reference Perman JA, Modler S, Barr RG, Rosenthal P. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology. 1984;87(6):1358–1363.PubMed Perman JA, Modler S, Barr RG, Rosenthal P. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology. 1984;87(6):1358–1363.PubMed
17.
go back to reference Thompson DG, Binfield P, De Belder A, O’Brien J, Warren S, Wilson M. Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut. 1985;26(12):1349–1352. doi:10.1136/gut.26.12.1349.PubMedCrossRef Thompson DG, Binfield P, De Belder A, O’Brien J, Warren S, Wilson M. Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut. 1985;26(12):1349–1352. doi:10.​1136/​gut.​26.​12.​1349.PubMedCrossRef
18.
go back to reference Perman JA, Modler S, Engel RR, Heldt G. Effect of ventilation on breath hydrogen measurements. J Lab Clin Med. 1985;105(4):436–439.PubMed Perman JA, Modler S, Engel RR, Heldt G. Effect of ventilation on breath hydrogen measurements. J Lab Clin Med. 1985;105(4):436–439.PubMed
19.
go back to reference Brummer RJ, Armbrecht U, Bosaeus I, Dotevall G, Stockbruegger RW. The hydrogen (H2) breath test. Sampling methods and the influence of dietary fiber on fasting level. Scand J Gastroenterol. 1985;20(8):1007–1013. doi:10.3109/00365528509088863.PubMedCrossRef Brummer RJ, Armbrecht U, Bosaeus I, Dotevall G, Stockbruegger RW. The hydrogen (H2) breath test. Sampling methods and the influence of dietary fiber on fasting level. Scand J Gastroenterol. 1985;20(8):1007–1013. doi:10.​3109/​0036552850908886​3.PubMedCrossRef
20.
go back to reference Solomons NW, Hamilton LH, Christman NT, Rothman D. Evaluation of a rapid breath hydrogen analyzer for clinical studies of carbohydrate absorption. Dig Dis Sci. 1983;28(5):397–404. doi:10.1007/BF02430527.PubMedCrossRef Solomons NW, Hamilton LH, Christman NT, Rothman D. Evaluation of a rapid breath hydrogen analyzer for clinical studies of carbohydrate absorption. Dig Dis Sci. 1983;28(5):397–404. doi:10.​1007/​BF02430527.PubMedCrossRef
22.
go back to reference Bond JH, Levitt MD, Prentiss R. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med. 1975;85(4):546–555.PubMed Bond JH, Levitt MD, Prentiss R. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med. 1975;85(4):546–555.PubMed
24.
go back to reference Bali A, Stableforth DE, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed). 1983;287(6398):1011–1013.CrossRef Bali A, Stableforth DE, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed). 1983;287(6398):1011–1013.CrossRef
25.
go back to reference Corazza GR, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology. 1987;93(1):53–58.PubMed Corazza GR, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology. 1987;93(1):53–58.PubMed
Metadata
Title
Influence of Previously Ingested Wheat on Fasting Breath Hydrogen in Celiac Patients
Authors
S. V. Rana
S. Sharma
S. K. Sinha
J. Kaur
K. K. Prasad
K. Singh
Publication date
01-06-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0496-3

Other articles of this Issue 6/2009

Digestive Diseases and Sciences 6/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.